143 related articles for article (PubMed ID: 1374842)
1. Epitope mapping of anti-breast and anti-ovarian mucin monoclonal antibodies.
Xing PX; Prenzoska J; McKenzie IF
Mol Immunol; 1992 May; 29(5):641-50. PubMed ID: 1374842
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a new MUC1 monoclonal antibody (VU-2-G7) directed to the glycosylated PDTR sequence of MUC1.
Ryuko K; Schol DJ; Snijdewint FG; von Mensdorff-Pouilly S; Poort-Keesom RJ; Karuntu-Wanamarta YA; Verstraeten RA; Miyazaki K; Kenemans P; Hilgers J
Tumour Biol; 2000; 21(4):197-210. PubMed ID: 10867613
[TBL] [Abstract][Full Text] [Related]
3. Second generation anti-MUC1 peptide monoclonal antibodies.
Xing PX; Prenzoska J; Quelch K; McKenzie IF
Cancer Res; 1992 Apr; 52(8):2310-7. PubMed ID: 1373108
[TBL] [Abstract][Full Text] [Related]
4. Effect of variations in peptide sequence on anti-human milk fat globule membrane antibody reactions.
Xing PX; Reynolds K; Pietersz GA; McKenzie IF
Immunology; 1991 Feb; 72(2):304-11. PubMed ID: 1707852
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibodies reactive with the breast carcinoma-associated mucin core protein repeat sequence peptide also recognise the ovarian carcinoma-associated sebaceous gland antigen.
Layton GT; Devine PL; Warren JA; Birrell G; Xing PX; Ward BG; McKenzie IF
Tumour Biol; 1990; 11(5):274-86. PubMed ID: 1697426
[TBL] [Abstract][Full Text] [Related]
6. Reactivity of anti-human milk fat globule antibodies with synthetic peptides.
Xing PX; Tjandra JJ; Reynolds K; McLaughlin PJ; Purcell DF; McKenzie IF
J Immunol; 1989 May; 142(10):3503-9. PubMed ID: 2715633
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies reacting with the MUC2 mucin core protein.
Devine PL; McGuckin MA; Birrell GW; Whitehead RH; Sachdev GP; Shield P; Ward BG
Br J Cancer; 1993 Jun; 67(6):1182-8. PubMed ID: 8512804
[TBL] [Abstract][Full Text] [Related]
8. Production of anti-breast cancer monoclonal antibodies using a glutathione-S-transferase-MUC1 bacterial fusion protein.
Apostolopoulos V; Xing PX; Trapani JA; McKenzie IF
Br J Cancer; 1993 Apr; 67(4):713-20. PubMed ID: 7682431
[TBL] [Abstract][Full Text] [Related]
9. T cells recognize PD(N/T)R motif common in a variable number of tandem repeat and degenerate repeat sequences of MUC1.
Pisarev VM; Kinarsky L; Caffrey T; Hanisch FG; Sanderson S; Hollingsworth MA; Sherman S
Int Immunopharmacol; 2005 Feb; 5(2):315-30. PubMed ID: 15652762
[TBL] [Abstract][Full Text] [Related]
10. Cellular mucins: targets for immunotherapy.
Apostolopoulos V; McKenzie IF
Crit Rev Immunol; 1994; 14(3-4):293-309. PubMed ID: 7538768
[TBL] [Abstract][Full Text] [Related]
11. Synthetic peptides reactive with anti-human milk fat globule membrane monoclonal antibodies.
Xing PX; Reynolds K; Tjandra JJ; Tang XL; McKenzie IF
Cancer Res; 1990 Jan; 50(1):89-96. PubMed ID: 2293561
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Pepscan analyses for epitope mapping of anti-MUC1 monoclonal antibodies--a comparative study and review of five antibodies.
Petrakou E; Murray A; Rosamund C; Graves L; Price MR
Anticancer Res; 1998; 18(6A):4419-21. PubMed ID: 9891503
[TBL] [Abstract][Full Text] [Related]
13. Human single-chain Fv antibodies to MUC1 core peptide selected from phage display libraries recognize unique epitopes and predominantly bind adenocarcinoma.
Henderikx P; Kandilogiannaki M; Petrarca C; von Mensdorff-Pouilly S; Hilgers JH; Krambovitis E; Arends JW; Hoogenboom HR
Cancer Res; 1998 Oct; 58(19):4324-32. PubMed ID: 9766660
[TBL] [Abstract][Full Text] [Related]
14. Fine specificity of antibody recognition of carcinoma-associated epithelial mucins: antibody binding to synthetic peptide epitopes.
Briggs S; Price MR; Tendler SJ
Eur J Cancer; 1993; 29A(2):230-7. PubMed ID: 7678496
[TBL] [Abstract][Full Text] [Related]
15. Peptide epitopes in breast cancer mucins.
Xing PX; Apostolopoulos V; Trapani J; Prenzoska J; McKenzie IF
Adv Exp Med Biol; 1994; 353():9-16. PubMed ID: 7527180
[No Abstract] [Full Text] [Related]
16. Epitope mapping of anti-MUC1 mucin protein core monoclonal antibodies.
Petrakou E; Murray A; Price MR
Tumour Biol; 1998; 19 Suppl 1():21-9. PubMed ID: 9422085
[TBL] [Abstract][Full Text] [Related]
17. Specificity analysis of sera from breast cancer patients vaccinated with MUC1-KLH plus QS-21.
Adluri S; Gilewski T; Zhang S; Ramnath V; Ragupathi G; Livingston P
Br J Cancer; 1999 Apr; 79(11-12):1806-12. PubMed ID: 10206297
[TBL] [Abstract][Full Text] [Related]
18. Natural human anti-Gal alpha(1,3)Gal antibodies react with human mucin peptides.
Sandrin MS; Vaughan HA; Xing PX; McKenzie IF
Glycoconj J; 1997 Jan; 14(1):97-105. PubMed ID: 9076519
[TBL] [Abstract][Full Text] [Related]
19. Immune recognition of linear epitopes in peptide fragments of epithelial mucins.
Briggs S; Price MR; Tendler SJ
Immunology; 1991 Aug; 73(4):505-7. PubMed ID: 1717370
[TBL] [Abstract][Full Text] [Related]
20. Humanization of an anti-mucin antibody for breast and ovarian cancer therapy.
Baker TS; Bose CC; Caskey-Finney HM; King DJ; Lawson AD; Lyons A; Mountain A; Owens RJ; Rolfe MR; Sehdev M
Adv Exp Med Biol; 1994; 353():61-82. PubMed ID: 7985543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
